Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-23-035215
Filing Date
2023-07-19
Accepted
2023-07-19 16:31:12
Documents
25
Period of Report
2023-07-19

Document Format Files

Seq Description Document Type Size
1 6-K ny20009815x1_6k.htm 6-K 14021
2 EXHIBIT 99.1 ny20009815x1_ex99-1.htm EX-99.1 43938
3 EXHIBIT 99.2 ny20009815x1_ex99-2.htm EX-99.2 1655408
4 EXHIBIT 99.3 ny20009815x1_ex99-3.htm EX-99.3 1589
5 EXHIBIT 99.4 ny20009815x1_ex99-4.htm EX-99.4 1720
6 EXHIBIT 99.5 ny20009815x1_ex99-5.htm EX-99.5 1681
7 EXHIBIT 99.6 ny20009815x1_ex99-6.htm EX-99.6 1633
8 ny20009815x1_ex99-1logo1.jpg GRAPHIC 8965
9 ny20009815x1_ex99-1logo2.jpg GRAPHIC 3005
10 ny20009815x1_ex99-1sig1.jpg GRAPHIC 2455
11 ny20009815x1_ex99-1sig2.jpg GRAPHIC 1756
12 ny20009815x1_ex99-2img001.jpg GRAPHIC 1965
13 ny20009815x1_ex99-2img002.jpg GRAPHIC 1435
14 ny20009815x1_ex99-2img003.jpg GRAPHIC 3249
15 ny20009815x1_ex99-2img004.jpg GRAPHIC 3772
16 ny20009815x1_ex99-2img005.jpg GRAPHIC 4320
17 ny20009815x1_ex99-2img006.jpg GRAPHIC 1940
18 ny20009815x1_ex99-3img01.jpg GRAPHIC 1155492
19 ny20009815x1_ex99-3img02.jpg GRAPHIC 944279
20 ny20009815x1_ex99-4img01.jpg GRAPHIC 1307087
21 ny20009815x1_ex99-4img02.jpg GRAPHIC 1148767
22 ny20009815x1_ex99-5img01.jpg GRAPHIC 1126019
23 ny20009815x1_ex99-5img02.jpg GRAPHIC 1412513
24 ny20009815x1_ex99-6img01.jpg GRAPHIC 977760
25 ny20009815x1_ex99-6img02.jpg GRAPHIC 1186856
  Complete submission text file 0001140361-23-035215.txt   14503527
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 231097042
SIC: 2834 Pharmaceutical Preparations